Suppr超能文献

8.1祖先主要组织相容性复合体单倍型与结直肠癌风险密切相关。

The 8.1 ancestral MHC haplotype is strongly associated with colorectal cancer risk.

作者信息

Tóth Eva Katalin, Kocsis Judit, Madaras Balázs, Bíró Adrienn, Pocsai Zsuzsa, Fust George, Blaskó Bernadett, Karádi István, Adány Róza, Laki Judit

机构信息

3rd Department of Medicine, Semmelweis University, Budapest, Hungary.

出版信息

Int J Cancer. 2007 Oct 15;121(8):1744-8. doi: 10.1002/ijc.22922.

Abstract

Many recent data indicate that some alleles encoded in the central major histocompatibility complex (MHC) region (Class III) of short arm of chromosome 6 may modify the risk of cancer development. Therefore we determined 4 single nucleotide polymorphisms (SNPs) of this region (TNF-alpha -308 G > A, RAGE -429 T > C, HSP70-2 -1267 A > G, LTA 252 A > G) in genomic DNA samples from 183 Hungarian patients with colorectal cancer and 141 age matched control subjects representing the Hungarian population of the same age and gender. No significant differences were found in either SNP tested. When, however, three- or four-locus haplotypes consisting of known constituents of the so-called 8.1 ancestral haplotype (8.1AH) were considered, marked differences were observed. Frequency of TNF-alpha -308A, RAGE -429C, HSP70-2 -1267G, LTA 252G (8.1AH) haplotype was significantly (p = 0.006) more frequent (19.1%) among patients than in the controls (7.7%). Age- and gender-adjusted ratio of the 8.1AH carriers vs. non-carriers to have colorectal cancer was 2.514 (1.130-5.594). This risk was higher in <or=67 years old subjects (4.073 (1.317-12.596)) and in females (3.771 (1.302-10.927). These findings-consistent with similar recent results with ovarian cancer-indicate that carriers of the 8.1AH, encoding for an altered immune response and known to be associated with alterations of several immune functions and autoimmune diseases have an increased risk for some cancer types. These findings may contribute to better understanding how the defense mechanisms against tumors could be enhanced/strengthened.

摘要

许多最新数据表明,位于6号染色体短臂中央主要组织相容性复合体(MHC)区域(III类)编码的一些等位基因可能会改变癌症发生的风险。因此,我们在183例匈牙利结直肠癌患者和141例年龄匹配的对照受试者(代表相同年龄和性别的匈牙利人群)的基因组DNA样本中,测定了该区域的4个单核苷酸多态性(SNP)(肿瘤坏死因子-α -308 G>A、晚期糖基化终末产物受体 -429 T>C、热休克蛋白70-2 -1267 A>G、淋巴毒素α 252 A>G)。在所检测的任何一个SNP中均未发现显著差异。然而,当考虑由所谓的8.1祖先单倍型(8.1AH)的已知成分组成的三位点或四位点单倍型时,观察到了明显差异。肿瘤坏死因子-α -308A、晚期糖基化终末产物受体 -429C、热休克蛋白70-2 -1267G、淋巴毒素α 252G(8.1AH)单倍型在患者中的频率(19.1%)显著高于对照组(7.7%)(p = 0.006)。8.1AH携带者与非携带者患结直肠癌的年龄和性别调整比值为2.514(1.130 - 5.594)。在≤67岁的受试者中(风险为4.073(1.317 - 12.596))和女性中(风险为3.771(1.302 - 10.927)),这种风险更高。这些发现与最近关于卵巢癌的类似结果一致,表明编码免疫反应改变且已知与多种免疫功能改变和自身免疫性疾病相关的8.1AH携带者患某些癌症类型的风险增加。这些发现可能有助于更好地理解如何增强/强化针对肿瘤的防御机制。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验